Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Apps News Health Apps Profiting From Copycat Weight Loss Drugs On Borrowed Time

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Apps News Health Apps Profiting From Copycat Weight Loss Drugs On Borrowed Time is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Apps News Health Apps Profiting From Copycat Weight Loss Drugs On Borrowed Time | RobinsPost News & Noticias

This era of weight loss drugs requires a new kind of health platform


The question now is how to best serve the millions who, freed from a lifetime of yo-yo dieting, are re-engaging with their health and looking for a helping hand. For many GLP-1 users, that success has ... Read More

Paying more for health insurance? Why weight-loss drugs may be driving up your premiums.


As open enrollment approaches, a variety of factors — including pricey GLP-1 weight-loss drugs — are poised to push already expensive premiums for employer-sponsored healthcare even higher in 2026, a ... Read More

Where the blockbuster weight loss drug market stands today — and what’s coming next


Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space. Read More

Costco to Sell Popular Weight-Loss Drugs Ozempic and Wegovy


Costco members will pay $499 a month out of pocket, the same price offered at CVS and Walmart, and on the manufacturer’s direct-to-consumer website. By Adeel Hassan The popular weight-loss drugs ... Read More

Trump's weight loss drug deal promises big savings — but some details are murky


Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers. Read More

How Novo Nordisk Gave Up Its Weight-Loss Gains


(Bloomberg) -- For a while, Danish drugmaker Novo Nordisk A/S looked unstoppable. It was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus